Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anu Paul

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Muscle & Nerve|February 22, 2018
Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosisRadhika Raheja, Keren Regev, Brian C Healy, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2023
Nasal administration of anti-CD3 mAb (Foralumab) downregulates <i>NKG7</i> and increases <i>TGFB1</i> and <i>GIMAP7</i> expression in T cells in subjects with COVID-19Thais G Moreira, Christian D Gauthier, Liam Murphy, et al.
International Journal of Molecular Sciences|May 13, 2023
Defective Induction of IL-27-Mediated Immunoregulation by Myeloid DCs in Multiple SclerosisFelipe von Glehn, Nathalie Pochet, Bibek Thapa, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2011
Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysisM Mercè Fernández-Balsells, Mohammad Hassan Murad, Amelia Barwise, et al.
JAMA Neurology|January 24, 2017
Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis SeverityKeren Regev, Brian C Healy, Fariha Khalid, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 4, 2018
Identification of MS-specific serum miRNAs in an international multicenter studyKeren Regev, Brian C Healy, Anu Paul, et al.
Multiple Sclerosis and Related Disorders|August 11, 2022
Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomesKathryn B Holroyd, Brian C Healy, Sarah Conway, et al.
The Journal of Clinical Investigation|March 17, 2022
microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balanceMai Fujiwara, Radhika Raheja, Lucien P Garo, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 17, 2022
Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MSHrishikesh Lokhande, Mattia Rosso, Shahamat Tauhid, et al.
Clinical Endocrinology|September 18, 2010
Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysisMohammad Hassan Murad, M M Fernández-Balsells, Amelia Barwise, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Muscle & Nerve|February 22, 2018
Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosisRadhika Raheja, Keren Regev, Brian C Healy, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2023
Nasal administration of anti-CD3 mAb (Foralumab) downregulates <i>NKG7</i> and increases <i>TGFB1</i> and <i>GIMAP7</i> expression in T cells in subjects with COVID-19Thais G Moreira, Christian D Gauthier, Liam Murphy, et al.
International Journal of Molecular Sciences|May 13, 2023
Defective Induction of IL-27-Mediated Immunoregulation by Myeloid DCs in Multiple SclerosisFelipe von Glehn, Nathalie Pochet, Bibek Thapa, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2011
Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysisM Mercè Fernández-Balsells, Mohammad Hassan Murad, Amelia Barwise, et al.
JAMA Neurology|January 24, 2017
Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis SeverityKeren Regev, Brian C Healy, Fariha Khalid, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 4, 2018
Identification of MS-specific serum miRNAs in an international multicenter studyKeren Regev, Brian C Healy, Anu Paul, et al.
Multiple Sclerosis and Related Disorders|August 11, 2022
Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomesKathryn B Holroyd, Brian C Healy, Sarah Conway, et al.
The Journal of Clinical Investigation|March 17, 2022
microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balanceMai Fujiwara, Radhika Raheja, Lucien P Garo, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 17, 2022
Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MSHrishikesh Lokhande, Mattia Rosso, Shahamat Tauhid, et al.
Clinical Endocrinology|September 18, 2010
Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysisMohammad Hassan Murad, M M Fernández-Balsells, Amelia Barwise, et al.
Pageof 9